Drugs that contain Acetaminophen; Benzhydrocodone Hydrochloride
1. Apadaz patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
| US9132125 | ZEVRA THERAP | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof |
Jul, 2030
(6 years from now) | |
| US9549923 | ZEVRA THERAP | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and uses thereof |
Jul, 2030
(6 years from now) | |
| US8748413 | ZEVRA THERAP | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof |
Jul, 2030
(6 years from now) | |
| US8461137 | ZEVRA THERAP | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof |
Feb, 2031
(6 years from now) | |
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8828978 | ZEVRA THERAP | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof |
Jul, 2030
(6 years from now) | |
Market Authorisation Date: 04 January, 2019
Treatment: Management of acute pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate
Dosage: TABLET;ORAL
More Information on Dosage
APADAZ family patents
